Capecitabine and oxaliplatin for advanced esophagogastric cancer

New England Journal of Medicine

Volumn 358, Issue 18, 2008, Pages 1965-

  Bölke, Edwin ^a   Peiper, Matthias ^a   Budach, Wilfried ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; OXALIPLATIN;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; ESOPHAGUS CANCER; HUMAN; LETTER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 42949091965     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc080178     Document Type: Letter

References (6)

1. D Cunningham N Starling S Rao Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358 2008 36 46
2. AM Mauer EH Kraut SA Krauss Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol 16 2005 1320 1325
3. G Kannarkat EE Lasher D Schiff Neurologic complications of chemotherapy agents. Curr Opin Neurol 20 2007 719 725
4. G Liu E Franssen MI Fitch E Warner Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15 1997 110 115
5. A Webb D Cunningham JH Scarffe Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 15 1997 261 267
6. P Ross M Nicolson D Cunningham Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20 2002 1996 2004